The instruction for medical use
of medicine
of the Tablet for cough - oz
the Trade name
of the Tablet for cough - OZ
the International unlicensed name
Is not present
the Dosage form
of the Tablet of 50 mg
Structure
One tablet contains
active agent: Mucaltinum (in terms of dry matter with the maintenance of neutral monosaccharides of 14.7%) – 50 mg,
excipients: Natrii hydrocarbonas, citric acid monohydrate, calcium stearate, sakharastvorafinad or granulated sugar.
The description
of the Tablet of color, gray or gray with a brownish shade, with impregnations, with a biconvex surface.
Pharmacotherapeutic group
Drugs for elimination of symptoms of cold and cough. Expectorant drugs.
The code of automatic telephone exchange R05C A05
the Pharmacological
Mucaltinum properties envelops a mucous membrane of a bronchial tree and renders anti-inflammatory effect, facilitates advance of a phlegm from the airways, lower in upper parts, and its expectoration at the expense of irritation of receptors of a stomach and reflex strengthening of the peristaltic movement of bronchioles and activity of a ciliary epithelium. Being soaked up after intake, Mucaltinum stimulates neurons of the emetic and respiratory centers, reflex strengthening secretion of bronchial glands, and reduces viscosity of a phlegm.
Indications
- expectorant in acute and chronic diseases of upper airways (bronchitis, pneumonia, a bronchoectatic disease, bronchial asthma, a pulmonary tuberculosis with the phenomena of nonspecific bronchitis) in complex therapy.
The route of administration and doses
accept Mucaltinum inside to food. Mucaltinum of a tablet is appointed to adults and children from 6 years on 1 - 2 tablets 3 - 4 times a day. Children can dissolve a tablet in 1/3 glasses of warm water, adding sweet syrup.
Duration of treatment is defined by the attending physician.
Side effects
- allergic reactions in the form of a small tortoiseshell, an itching of skin.
If by-effects arise, then it is necessary to stop administration of drug.
Contraindications
- hypersensitivity to active agent and to drug components
- children's age up to 6 years
- a peptic ulcer of a stomach and a 12-perstny gut
Medicinal interactions
are not established
Special instructions
Sometimes at treatment of patients with chronic inflammatory diseases of lungs in the first days of treatment of Mucaltinum the viscosity of a phlegm increases that is caused by department of the phlegm which collected in a bronchial tree containing a large number of a detritis, proteins and inflammatory elements. At diffusion damage of bronchial tubes, significant changes in physical and chemical properties of a phlegm and decrease in mukotsiliarny transport the combination of Mucaltinum and mucolytic drugs is necessary (Bromhexine, Acetylcysteinum and/or proteolytic enzymes. Mucaltinum should not be applied along with the drugs containing codeine and other anti-inflammatory drugs as it complicates expectoration of the diluted phlegm.
Overdose
Symptoms: nausea, vomiting.
Treatment: symptomatic therapy.
A form of release and packing
On 30 tablets in banks of medicines, polymeric for packing, corked by covers with control of the first opening. After 1 bank together with the instruction for medical use in the state and Russian languages put in a pack from cardboard. On 10 tablets in planimetric bezjyacheykovy package with the paper laminated by polyethylene.
To Store storage conditions in the dry, protected from light place at a temperature from 8 °C to 15 °C.
To store out of children's reach!
3 years
not to use a period of storage after expiry date.
Prescription status
Without prescription
LLC GNCLS Experimental Plant Producer, Ukraine, Kharkiv, Vorobyov St., 8.
The owner of the registration certificate
of LLC GNCLS Experimental Plant, Ukraine
the Address of the organization accepting in the territory of the Republic of Kazakhstan claims from consumers on quality of products (goods) the Address: LLC GNCLS Experimental Plant Ukraine, Kharkiv, st. Vorobyova, 8 Phone number: (057) 752-30-17Факс: (057) 752-30-17Адрес e-mail: office@gncls.com.ua
of medicine
of the Tablet for cough - oz
the Trade name
of the Tablet for cough - OZ
the International unlicensed name
Is not present
the Dosage form
of the Tablet of 50 mg
Structure
One tablet contains
active agent: Mucaltinum (in terms of dry matter with the maintenance of neutral monosaccharides of 14.7%) – 50 mg,
excipients: Natrii hydrocarbonas, citric acid monohydrate, calcium stearate, sakharastvorafinad or granulated sugar.
The description
of the Tablet of color, gray or gray with a brownish shade, with impregnations, with a biconvex surface.
Pharmacotherapeutic group
Drugs for elimination of symptoms of cold and cough. Expectorant drugs.
The code of automatic telephone exchange R05C A05
the Pharmacological
Mucaltinum properties envelops a mucous membrane of a bronchial tree and renders anti-inflammatory effect, facilitates advance of a phlegm from the airways, lower in upper parts, and its expectoration at the expense of irritation of receptors of a stomach and reflex strengthening of the peristaltic movement of bronchioles and activity of a ciliary epithelium. Being soaked up after intake, Mucaltinum stimulates neurons of the emetic and respiratory centers, reflex strengthening secretion of bronchial glands, and reduces viscosity of a phlegm.
Indications
- expectorant in acute and chronic diseases of upper airways (bronchitis, pneumonia, a bronchoectatic disease, bronchial asthma, a pulmonary tuberculosis with the phenomena of nonspecific bronchitis) in complex therapy.
The route of administration and doses
accept Mucaltinum inside to food. Mucaltinum of a tablet is appointed to adults and children from 6 years on 1 - 2 tablets 3 - 4 times a day. Children can dissolve a tablet in 1/3 glasses of warm water, adding sweet syrup.
Duration of treatment is defined by the attending physician.
Side effects
- allergic reactions in the form of a small tortoiseshell, an itching of skin.
If by-effects arise, then it is necessary to stop administration of drug.
Contraindications
- hypersensitivity to active agent and to drug components
- children's age up to 6 years
- a peptic ulcer of a stomach and a 12-perstny gut
Medicinal interactions
are not established
Special instructions
Sometimes at treatment of patients with chronic inflammatory diseases of lungs in the first days of treatment of Mucaltinum the viscosity of a phlegm increases that is caused by department of the phlegm which collected in a bronchial tree containing a large number of a detritis, proteins and inflammatory elements. At diffusion damage of bronchial tubes, significant changes in physical and chemical properties of a phlegm and decrease in mukotsiliarny transport the combination of Mucaltinum and mucolytic drugs is necessary (Bromhexine, Acetylcysteinum and/or proteolytic enzymes. Mucaltinum should not be applied along with the drugs containing codeine and other anti-inflammatory drugs as it complicates expectoration of the diluted phlegm.
Overdose
Symptoms: nausea, vomiting.
Treatment: symptomatic therapy.
A form of release and packing
On 30 tablets in banks of medicines, polymeric for packing, corked by covers with control of the first opening. After 1 bank together with the instruction for medical use in the state and Russian languages put in a pack from cardboard. On 10 tablets in planimetric bezjyacheykovy package with the paper laminated by polyethylene.
To Store storage conditions in the dry, protected from light place at a temperature from 8 °C to 15 °C.
To store out of children's reach!
3 years
not to use a period of storage after expiry date.
Prescription status
Without prescription
LLC GNCLS Experimental Plant Producer, Ukraine, Kharkiv, Vorobyov St., 8.
The owner of the registration certificate
of LLC GNCLS Experimental Plant, Ukraine
the Address of the organization accepting in the territory of the Republic of Kazakhstan claims from consumers on quality of products (goods) the Address: LLC GNCLS Experimental Plant Ukraine, Kharkiv, st. Vorobyova, 8 Phone number: (057) 752-30-17Факс: (057) 752-30-17Адрес e-mail: office@gncls.com.ua
Related Products
Bayer Consumer Care AG, Switzerland, produced Bayer Bitterfeld G
Alka-Seltzer effervescent (10 tablets)
$14.80
Vitale-XD Ltd / Pharma Estika Manufacturing (Estonia)
Asibroks 10s 600 mg effervescent tablets
$10.50